Latest news
Akari Therapeutics Highlights WhiteHawk Collaboration and Dual-Payload ADC Strategy in CEO Corner Segment - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 13:01:00 GMTTargeted therapy combinations may overcome treatment resistance in advanced prostate cancer - Bioengineer.orgBioengineer.org · Tue, 04 Aug 2026 01:08:10 GMT